SCHEMBL22355447

SCHEMBL22355447

Oc1ccc2c(n1)CNC[C@@H](C(F)(F)F)O2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22355451 1.00
SCHEMBL22355448 1.00
Hydrochloric Acid SCHEMBL29694258 0.99
Hydrochloric Acid SCHEMBL29694224 0.99
SCHEMBL22355462 0.85 KDM4E (0.30)
SCHEMBL30850050 0.85 KDM4E (0.30)
SCHEMBL22355459 0.77 NTRK1 (0.35)
SCHEMBL22355519 0.77 NTRK1 (0.35)
SCHEMBL22355454 0.77 NTRK1 (0.35)
Hydrochloric Acid SCHEMBL30850013 0.76 NTRK1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204526-A1 HYDROXYPYRIDOXAZEPINES AS NRF2 ACTIVATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2022-06-30 US disclosed
WO-2020165776-A1 HYDROXYPYRIDOXAZEPINES AS NRF2 ACTIVATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-08-20 WO disclosed